
Keywords: AA; Arachidonic acid; ALX/FPR2; Lipoxin A4/formyl peptide receptor 2; AnxA1; Annexin A1; ASA; Acetylsalicylic acid; AT; Aspirin-triggered; BHR; Bronchial hyper-reactivity; COX; Cyclooxygenase; DHA; Docosahexaenoic acid; Eos; Eosinophils; EPA; Eicosapentae